| Literature DB >> 35962373 |
Jia-Sen Hu1, Cheng-Bin Huang1,2, Shu-Ming Mao1, Kang-Hao Fang1, Zong-Yi Wu1, You-Ming Zhao3.
Abstract
BACKGROUND: Compared with open comminuted calcaneal fractures, less emphasis is placed on postoperative surgical site infection (SSI) of closed comminuted calcaneal fractures. This study aimed to identify the risk factors associated with SSI and build a nomogram model to visualize the risk factors for postoperative SSI.Entities:
Keywords: Closed comminuted calcaneal fractures; Nomogram model; Risk factor; Surgical site infection
Mesh:
Substances:
Year: 2022 PMID: 35962373 PMCID: PMC9373506 DOI: 10.1186/s12893-022-01735-4
Source DB: PubMed Journal: BMC Surg ISSN: 1471-2482 Impact factor: 2.030
Comparison of preoperative clinical characteristics and preoperative laboratory parameters between two groups
| Non-SSI (170) | SSI (44) | P value | |
|---|---|---|---|
| Age (years) | 46.12 ± 11.45 | 47.25 ± 11.08 | 0.559 |
| BMI | 23.94 (22.24–25.49) | 24.12 (22.31–25.81) | 0.374 |
| < 0.001 | |||
| Low fall injury (< 2 m) | 104 (61.2) | 11 (25.0) | |
| High fall injury (> 2 m) | 66 (38.8) | 33 (75.0) | |
| Injury-surgery interval (days) | 4 (3–5) | 5 (3.25–7) | 0.044 |
| Operative time (minutes) | 70 (60–81) | 93 (80–104) | < 0.001 |
| Operative blood loss (mL) | 50 (20–50) | 85 (50–100) | < 0.001 |
| 0.819 | |||
| Female, n (%) | 21 (12.4) | 6 (13.6) | |
| Male, n (%) | 149 (87.6) | 38 (86.4) | |
| 0.022 | |||
| Outpatient, n (%) | 79 (46.5) | 12 (27.3) | |
| Emergency, n (%) | 91 (53.5) | 32 (72.7) | |
| Current drinking, n (%) | 75 (44.1) | 19 (43.2) | 0.911 |
| Current smoking, n (%) | 66 (38.8) | 21 (47.7) | 0.284 |
| 0.317 | |||
| Left, n (%) | 90 (52.9) | 27 (61.4) | |
| Right, n (%) | 80 (47.1) | 17 (38.6) | |
| Artificial bone graft, n (%) | 129 (75.9) | 35 (79.5) | 0.609 |
| 0.019 | |||
| Tarsal sinus approach, n (%) | 58 (34.1) | 7 (15.9) | |
| Extended lateral approach, n (%) | 112 (65.9) | 37 (84.1) | |
| 0.054 | |||
| Combined spinal and epidural anesthesia, n (%) | 146 (85.9) | 32 (72.7) | |
| General anesthesia, n (%) | 16 (9.4) | 10 (22.7) | |
| Spinal anesthesia, n (%) | 8 (4.7) | 2 (4.5) | |
| Preoperative mannitol, n (%) | 143 (84.1) | 36 (81.8) | 0.713 |
| 0.066 | |||
| First-generation cephalosporins, n (%) | 6 (3.5) | 4 (9.1) | |
| Second-generation cephalosporins, n (%) | 68 (40.0) | 15 (34.1) | |
| Third-generation cephalosporin, n (%) | 13 (7.6) | 5 (11.4) | |
| Latamoxef Sodium, n (%) | 16 (9.4) | 5 (11.4) | |
| Clindamycin, n (%) | 21 (12.4) | 9 (20.5) | |
| Azlocillin, n (%) | 13 (7.6) | 2 (20.5) | |
| Amoxicillin, n (%) | 18 (10.6) | 0 | |
| Flucloxacillin, n (%) | 15 (8.8) | 4 (9.1) | |
| Postoperative drainage tube, n (%) | 54 (31.8) | 10 (22.7) | 0.243 |
| Hypertension, n (%) | 34 (20.0)) | 8 (18.2 | 0.787 |
| Diabetes, n (%) | 14 (8.2) | 3 (6.8) | 0.757 |
| Fatty liver, n (%) | 72 (42.4) | 13 (15.3) | 0.122 |
| Kidney stone, n (%) | 27 (15.9) | 3 (6.8) | 0.123 |
| Pneumonia, n (%) | 20 (11.8) | 5 (11.4) | 0.941 |
| 0.218 | |||
| Low-risk, n (%) | 80 (47.1) | 26 (59.1) | |
| Medium risk, n (%) | 39 (22.9) | 7 (15.9) | |
| High risk, n (%) | 51 (30.0) | 11 (25.0) | |
| 0.521 | |||
| Illiteracy, n (%) | 1 (2.3) | 13 (7.6) | |
| Primary, n (%) | 14 (31.8) | 49 (28.8) | |
| Junior middle, n (%) | 19 (43.2) | 78 (45.9) | |
| High school, n (%) | 9 (20.5) | 19 (11.2) | |
| Bachelor degree or above, n (%) | 1 (2.3) | 11 (6.5) | |
| Prealbumin (mg/L) | 262.62 ± 57.32 | 228.70 ± 57.49 | 0.001 |
| Total protein (g/L) | 68.21 ± 5.39 | 67.86 ± 5.83 | 0.708 |
| Albumin (g/L) | 41.9 (39.7–44.5) | 41.7 (37.6–44.1) | 0.164 |
| Globulin (g/L) | 26.15 ± 3.12 | 26.99 ± 3.51 | 0.122 |
| A/G | 1.6 (1.5–1.7) | 1.5 (1.4–1.7) | 0.018 |
| AST (U/L) | 21.0 (18.0–26.0) | 23.5 (20.0–30.8) | 0.038 |
| ALT (U/L) | 21 (15–32) | 23 (16–33) | 0.600 |
| AST/ALT | 0.96 (0.73–1.33) | 1.10 (0.82–1.44) | 0.143 |
| ALP (U/L) | 72.0 (63.5–87.0) | 69.0 (58.5–83.8) | 0.198 |
| GGT (U/L) | 29.0 (20.0–59.5) | 31.5 (18.3–50.3) | 0.776 |
| Total bilirubin (umol/L) | 15.4 (11.8–20.6) | 16.5 (13.5–20.1) | 0.289 |
| Direct Bilirubin (umol/L) | 4.0 (2.9–5.1) | 4.3 (3.6–6.0) | 0.112 |
| Indirect Bilirubin (umol/L) | 11.3 (8.6–15.7) | 12.9 (10.2–15.2) | 0.255 |
| FBG (mmol/L) | 5.38 (4.82–6.37) | 5.33 (4.88–6.43) | 0.990 |
| BUN (mmol/L) | 5.30 (4.40–6.70) | 4.89 (4.33–6.40) | 0.270 |
| Scr (umol/L) | 65.55 ± 12.01 | 63.60 ± 12.19 | 0.338 |
| BUN/Scr | 0.08 (0.07–0.1) | 0.08 (0.07–0.10) | 0.736 |
| Cystatin-C (mg/L) | 0.89 (0.78–0.99) | 0.79 (0.68–0.93) | < 0.001 |
| CPK (U/L) | 259 (165–442) | 475 (200.25–599) | 0.007 |
| Homocysteine (umol/L) | 9.60 (8.10–11.20) | 10.35 (8.88–11.20) | 0.180 |
| LDH (U/L) | 190 (171–212) | 202 (173–233) | 0.174 |
| Cholinesterase (U/L) | 8973 (7645–10,222) | 8224 (7064–8650) | 0.006 |
| Blood uric acid (umol/L) | 350.81 ± 98.65 | 318.93 ± 96.28 | 0.056 |
| Serum sodium (mmol/L) | 139.5 (138.2–141.0) | 139.2 (137.3–141.3) | 0.384 |
| Serum kalium (mmol/L) | 3.86 (3.63–4.10) | 3.96 (3.78–4.17) | 0.195 |
| Serum calcium (mmol/L) | 2.25 ± 0.12 | 2.24 ± 0.11 | 0.586 |
| Serum chlorine (mmol/L) | 104.89 ± 2.33 | 104.45 ± 2.36 | 0.265 |
| WBC (109/L) | 8.18 (6.83–10.85) | 9.36 (7.21–10.84) | 0.334 |
| Neutrophils (109/L) | 5.69 (4.66–8.23) | 6.96 (4.83–8.60) | 0.302 |
| Lymphocyte (109/L) | 1.56 (1.20–1.98) | 1.57 (1.17–1.97) | 0.969 |
| Monocyte (109/L) | 0.54 ± 0.23 | 0.57 ± 0.27 | 0.427 |
| Eosinophilic granulocyte (109/L) | 0.08 (0.03–0.16) | 0.04 (0.01–0.12) | 0.012 |
| Basophilic granulocyte (109/L) | 0.012 (0.007–0.022) | 0.012 (0.008–0.198) | 0.593 |
| RBC (1012/L) | 4.53 ± 0.53 | 4.47 ± 0.60 | 0.489 |
| Hemoglobin (g/L) | 151 (141–157) | 151 (144–156.5) | 0.832 |
| Hematocrit | 0.41 (0.39–0.44) | 0.42 (0.38–0.44) | 0.533 |
| MCV (fl) | 90.90 (88.05–93.55) | 91.35 (88.55–94.28) | 0.423 |
| MCH (pg) | 31 (29.8–31.9) | 30.9 (30.05–32.15) | 0.973 |
| MCHC (g/L) | 340.72 ± 10.56 | 339.43 ± 10.75 | 0.474 |
| Platelet count (109/L) | 217.36 ± 58.50 | 214.18 ± 67.07 | 0.756 |
| Plateletcrit | 0.22 (0.19–0.26) | 0.21 (0.19–0.26) | 0.920 |
| PDW, n (%) | 14 (11.90–15.90) | 13.35 (11.90–15.48) | 0.486 |
| MPV (fl) | 10.36 ± 1.02 | 10.54 ± 1.15 | 0.304 |
BMI body mass index; VTE venous thrombus embolism; WBC, white blood cell; RBC, red blood cell; MPV, mean platelet volume; AST, aspartate aminotransferase; ALT, alanine aminotransferase; A/G, albumin/globulin, CPK, creatine phosphate kinase; BUN, blood urea nitrogen; Scr, serum creatinine; MCHC, mean corpusular hemoglobin concerntration; ALP, alkaline phosphatase; GGT, gamma-glutamyltransferase; FBG, fasting blood glucose; LDH, lactate dehydrogenase; MCV, mean corpuscular volume; PDW, platelet distribution width; MCH, mean corpuscular hemoglobin
Univariate logistics regressions analysis of risk factors to closed comminuted calcaneal fracture patients with surgical site infection
| Variables | OR | 95%CI | P |
|---|---|---|---|
| Injury-surgery interval (days) | 1.116 | 0.992–1.256 | 0.068 |
| High-fall injury | 4.727 | 2.236–9.996 | < 0.001 |
| Operative time (minutes) | 1.042 | 1.024–1.060 | < 0.001 |
| Operative blood loss (ml) | 1.011 | 1.003–1.018 | 0.005 |
| Types of admission | 2.315 | 1.117–4.798 | 0.024 |
| Surgical approach | 2.737 | 1.149–6.519 | 0.023 |
| Prealbumin (mg/L) | 0.990 | 0.984–0.996 | 0.001 |
| Albumin (g/L) | 0.919 | 0.853–0.990 | 0.026 |
| A/G | 0.196 | 0.042–0.914 | 0.038 |
| AST (U/L) | 1.026 | 1.002–1.050 | 0.031 |
| Total bilirubin (umol/L) | 1.031 | 0.995–1.068 | 0.097 |
| Direct Bilirubin (umol/L) | 1.162 | 1.024–1.319 | 0.020 |
| Cystatin-C (mg/L) | 0.007 | 0.001–0.092 | < 0.001 |
| CPK (U/L) | 1.001 | 1.000–1.002 | 0.022 |
| LDH (U/L) | 1.007 | 1.000–1.015 | 0.059 |
| Cholinesterase (U/L) | 1.000 | 1.000–1.000 | 0.017 |
| Blood uric acid (umol/L) | 0.997 | 0.993–1.000 | 0.058 |
| Eosinophilic granulocyte (10^9/L) | 0.008 | 0.001–0.553 | 0.026 |
AST, aspartate aminotransferase; A/G, albumin/globulin, CPK, creatine phosphate kinase; LDH, lactate dehydrogenase
Multivariate logistics regressions analysis of risk factors to closed comminuted calcaneal fracture patients with surgical site infection
| Variables | OR | 95%CI | P |
|---|---|---|---|
| High-fall injury | 5.565 | 2.220–13.951 | < 0.001 |
| Operative time (minutes) | 1.044 | 1.023–1.064 | < 0.001 |
| Prealbumin (mg/L) | 0.988 | 0.980–0.995 | 0.001 |
| AST (U/L) | 1.035 | 1.004–1.067 | 0.027 |
| Cystatin-C (mg/L) | 0.010 | 0.001–0.185 | 0.002 |
AST, aspartate aminotransferase
Fig. 1Discriminatory accuracy for predicting calcaneal fracture patients with SSI by receiver operator characteristics (ROC) analysis calculating area under the curve (AUC)
Fig. 2A nomogram to predict the incidence of SSI in calcaneal fracture patients
Fig. 3Example of using nomogram to predict SSI
Fig. 4Calibration curve for nomogram prediction of SSI in calcaneal fracture patients